We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+24.52%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$11.9B
AUM Growth
-$101M
(-0.84%)
Cap. Flow
-$1.72B
Cap. Flow
% of AUM
-14.47%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,692
New
482
Increased
315
Reduced
482
Closed
413
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$242M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$187M |
| 3 |
AstraZeneca
AZN
|
+$163M |
| 4 |
Lockheed Martin
LMT
|
+$162M |
| 5 |
S&P Global
SPGI
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$234M |
| 2 |
Johnson & Johnson
JNJ
|
+$185M |
| 3 |
Mercado Libre
MELI
|
+$136M |
| 4 |
Procter & Gamble
PG
|
+$128M |
| 5 |
Shopify
SHOP
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.38% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Industrials | 11.12% |
| 5 | Communication Services | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Synopsys
SNPS
$78.8B
| $5.58M | 0.05% |
+21,525
| New | +$4.96M |
|
427
Integra LifeSciences
IART
$1.42B
| $5.56M | 0.05% |
85,658
-39,201
| -31% | -$2.11M |
|
428
Paycom
PAYC
$10.1B
| $5.56M | 0.05% |
+12,289
| New | +$4.9M |
|
429
Chemours
CC
$2.3B
| $5.53M | 0.05% |
223,036
-110,476
| -33% | -$2.63M |
|
430
FMC
FMC
$1.27B
| $5.53M | 0.05% |
48,099
+8,247
| +21% | +$918K |
|
|
DOYU
431
DouYu International Holdings
DOYU
$136M
| $5.52M | 0.05% |
49,919
-3,629
| -7% | -$492K |
|
432
Brown & Brown
BRO
$24B
| $5.49M | 0.05% |
+115,806
| New | +$5.33M |
|
433
Suncor Energy
SU
$76.5B
| $5.42M | 0.05% |
323,085
-400,910
| -55% | -$5.89M |
|
434
Adient
ADNT
$1.54B
| $5.39M | 0.05% |
154,960
+104,007
| +204% | +$2.93M |
|
435
TriNet
TNET
$3.22B
| $5.38M | 0.05% |
66,741
+15,989
| +32% | +$1.18M |
|
|
UNVR
436
DELISTED
Univar Solutions Inc.
UNVR
| $5.37M | 0.05% |
+282,345
| New | +$5.09M |
|
437
Campbell Soup
CPB
$6.94B
| $5.34M | 0.04% |
+110,392
| New | +$5.33M |
|
438
Corning
GLW
$137B
| $5.32M | 0.04% |
+147,807
| New | +$5.25M |
|
439
Ollie's Bargain Outlet
OLLI
$4.7B
| $5.32M | 0.04% |
65,075
-272,343
| -81% | -$23.8M |
|
440
Royal Gold
RGLD
$19.1B
| $5.3M | 0.04% |
49,855
+47,541
| +2,054% | +$5.49M |
|
|
TRTN
441
DELISTED
Triton International Limited
TRTN
| $5.29M | 0.04% |
109,040
+15,231
| +16% | +$644K |
|
442
Village Farms International
VFF
$302M
| $5.27M | 0.04% |
+519,480
| New | +$3.92M |
|
443
Watts Water Technologies
WTS
$12.8B
| $5.26M | 0.04% |
43,194
+10,067
| +30% | +$1.15M |
|
444
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
| $5.25M | 0.04% |
93,278
-22,822
| -20% | -$1.25M |
|
445
Everest Group
EG
$14B
| $5.24M | 0.04% |
22,375
+20,475
| +1,078% | +$4.52M |
|
446
Kontoor Brands
KTB
$4.65B
| $5.23M | 0.04% |
+128,834
| New | +$4.75M |
|
447
Henry Schein
HSIC
$10B
| $5.21M | 0.04% |
77,976
+69,531
| +823% | +$4.49M |
|
448
Bruker
BRKR
$8.83B
| $5.17M | 0.04% |
95,540
+1,627
| +2% | +$78K |
|
449
CDW
CDW
$17.8B
| $5.17M | 0.04% |
39,200
-30,317
| -44% | -$3.97M |
|
450
Phreesia
PHR
$780M
| $5.16M | 0.04% |
+95,111
| New | +$4.08M |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, Voloridge Investment Management held 1,692 positions worth $11.9B, down 0.84% from $12B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Voloridge Investment Management withdrew a net $1.72B in Q4 2020, closing 413 positions and reducing 482 holdings. Its most notable exit was Wells Fargo, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in AstraZeneca worth $154M.
- Voloridge Investment Management's largest Q4 2020 buy was AstraZeneca: 1,542,881 shares worth $154M.
- Voloridge Investment Management added most to Microsoft in Q4 2020, an estimated $242M increase.
- Voloridge Investment Management's biggest Q4 2020 reduction was Citigroup, cutting an estimated $234M.
- Voloridge Investment Management fully exited Wells Fargo in Q4 2020, selling an estimated $111M.
- Voloridge Investment Management's ten largest holdings make up 17% of its $11.9B portfolio in Q4 2020.
- Voloridge Investment Management opened 482 new positions and closed 413 in Q4 2020.
- Voloridge Investment Management's portfolio value fell 0.84% quarter-over-quarter to $11.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.